UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001606
Receipt number R000001927
Scientific Title Clinical trial of the new treatment for osteonecrosis of lunate bone using autologous bone marrow stromal cells
Date of disclosure of the study information 2008/12/27
Last modified on 2020/01/06 08:58:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical trial of the new treatment for osteonecrosis of lunate bone using autologous bone marrow stromal cells

Acronym

Clinical trial for osteonecrosis using autologous bone marrow stromal cells

Scientific Title

Clinical trial of the new treatment for osteonecrosis of lunate bone using autologous bone marrow stromal cells

Scientific Title:Acronym

Clinical trial for osteonecrosis using autologous bone marrow stromal cells

Region

Japan


Condition

Condition

Osteonecrosis of the Lunate bone

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To analyze the safety and efficacy of mesenchymal stem cell transplantation for osteonecrosis of lunate bone

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Phase I,II


Assessment

Primary outcomes

X-ray evaluation of clinical stage on the point of preoperation and two years after operation

Key secondary outcomes

Clinical score and bone volume on the point of preoperation, one year after operaion and two years after operation


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Period: 2 years
Volume:10000000 of mesenchymal stem cell
Number:1
Case number intervention: 10 cases

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

Clinical stage of Xray evaluation (Lichtman classification;Stage 3A and Stage 3B)

Key exclusion criteria

Previous medical history against candidate bone
Heavy smorker (Brinkman index>600)
Warfarin treatment
Diabetes mellitus (HbA1c>9.0%)
Arteriosclerosis obliterans
Pregnancy,during lactation
Malignant neoplasm
Cardiac infarction, brain infaction
Rheumatoid arthritis
Dialytic therapy
Complication of blood disease
Live less than 12 months
Active infection
Hypotension(systolic blood pressure<90mmHg)
Low body weight(under 40kg)
Bone marrow dysfunction (neutrophil<1500/mm3, Hb<11.0g/dL(male),Hb<10.0g/dL(women), Plt<100000/mm3)
Patient with the anti-osteoporosis drug and steroid were changed within 3 months
Patient which was judged as inadequate

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Junya
Middle name
Last name Toguchida

Organization

Institute for Frontier Medical Sciences, Kyoto University

Division name

Department of Tissue Regeneration

Zip code

606-8507

Address

53 Kawahara-cho Shogoin Sakyo-ku Kyoto City

TEL

075-751-4134

Email

togjun@frontier.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Izumi
Middle name
Last name Hashimoto

Organization

Kyoto University Hospital

Division name

Department of Orthopaedic Surgery

Zip code

606-8501

Address

54 Kawahara-cho Shogoin Sakyo-ku Kyoto city

TEL

075-751-4400

Homepage URL

http://www.kuhp.kyoto-u.ac.jp/~seikeigeka/

Email

seikei@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Department of Orthopedic Surgery, Kyoto University Hospital

Institute

Department

Personal name



Funding Source

Organization

Kyoto University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Center for Cell and Molecular Therapy, Kyoto University

Name of secondary funder(s)

Ministry of Health, Labor, and Welfare Ministry of Education, Culture, Sports, Science, and Technology
New Energy and Industrial Technology Development Organization


IRB Contact (For public release)

Organization

Kyoto University Graduate School and Faculty of Medicine, Ethics Committee

Address

Yoshida-Konoe-cho, Sakyo-ku, Kyoto

Tel

075-753-4680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 12 Month 27 Day


Related information

URL releasing protocol

no protocol

Publication of results

Published


Result

URL related to results and publications

https://www.ncbi.nlm.nih.gov/pubmed/28274511

Number of participants that the trial has enrolled

5

Results

Progression of radiographic stage (Lichtman
classification)was not recognized in all cases.
Average Stahl's index was decreased.
Average bone volume was decreased.

Results date posted

2020 Year 01 Month 06 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2017 Year 05 Month 06 Day

Baseline Characteristics

stage 3A and 3B

Participant flow

Recruited from outpatient

Adverse events

No Adverse Event

Outcome measures

modified Mayo Wrist Score
Stahl's index

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 08 Month 01 Day

Date of IRB

2007 Year 08 Month 01 Day

Anticipated trial start date

2007 Year 08 Month 01 Day

Last follow-up date

2014 Year 03 Month 01 Day

Date of closure to data entry

2014 Year 05 Month 01 Day

Date trial data considered complete

2014 Year 05 Month 01 Day

Date analysis concluded

2014 Year 06 Month 01 Day


Other

Other related information



Management information

Registered date

2008 Year 12 Month 27 Day

Last modified on

2020 Year 01 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001927


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name